[1]Lv M, Yang D, Ji X, et al. Effect of WenXin KeLi on improvement of arrhythmia after myocardial infarction by intervening PI3K-AKT-mTOR autophagy pathway[J]. Evid Based Complement Alternat Med, 2022, 2022:2022970-2022983.
[2] Yuan YH, Yuan R, Miao Y, et al. Effect and mechanism of Huangqi Shengmai Decoction in treatment of joint rat model of fatigue and myocardial injury[J]. China Journal of Chinese Materia Medica, 2022, 47(19):5292-5298. (in Chinese)
袁亚慧, 袁蓉, 缪宇, 等. 黄芪生脉饮对疲劳合并心肌损伤大鼠模型的作用及相关机制[J].中国中药杂志, 2022, 47(19):5292-5298.
[3] Song W, Dai B, Dai Y. Influence of ginsenoside Rh2 on cardiomyocyte pyroptosis in rats with acute myocardial infarction[J]. Evid Based Complement Alternat Med, 2022, 2022:5194523-5194532.
[4] Li B, Yao BC, Chen QL, et al. The protective role and mechanism of liriodendrin in rats with myocardial infarction[J]. J Thorac Dis, 2022, 14(1):135-146.
[5] Yu L, Yang Y, Wang J, et al. PDCD4 promotes inflammation/fibrosis by activating the PPAR-γ/NF-κB pathway in mouse atrial myocytes[J]. Mol Med Rep, 2024, 30(5):209-218.
[6] Wang C, Cui C, Xie X, et al. Calcitriol attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behaviors by suppressing the P2X7R/NLRP3/caspase-1 pathway[J]. Psychopharmacology (Berl), 2024, 241(7):1329-1343.
[7] Zhang SJ, Huang CX, Zhao QY, et al. Macrophage colony-stimulating factor ameliorates myocardial injury in mice after myocardial infarction by regulating cardiac macrophages through the P2X7R/NLRP3/IL-1β signal pathway[J]. Heliyon, 2023, 9(10):e20805-e20814.
[8] Xiao JL, Zou X, Dan JP. Effect of alfentanil on myocardial fibrosis in rats with acute myocardial infarction by regulating the SphK1/S1P signaling pathway[J]. China Jourmal of Chinese Materia Medica, 2024, 35(8):955-960. (in Chinese)
肖锦亮, 邹雪, 但家朋. 阿芬太尼调节SphK1/S1P信号通路对急性心肌梗死大鼠心肌纤维化的影响[J]. 中国中药杂志, 2024, 35(8):955-960.
[9] Duan YF, Gu J, Liu R, et al. Huangqi Shengmai Yin protects against radiation-induced cardiac inflammatory-fibrotic damage[J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2020, 31(1):29-36. (in Chinese)
段依璠, 顾静, 刘润, 等. 黄芪生脉饮防护放射诱导的心脏炎性-纤维化损伤作用研究[J]. 中药新药与临床药理, 2020, 31(1):29-36.
[10] Lü YT, Wang YCh, Feng YD, et al. Study on the pharmacodynamics and mechanism of Blumea balsamifera total flavonoids against acute myocardial infarction model rats[J]. China Pharmacy, 2023, 34(11):1332-1336. (in Chinese)
吕依婷, 王溢晨, 冯贻东, 等. 艾纳香总黄酮对急性心肌梗死模型大鼠的药效作用及机制研究[J]. 中国药房, 2023, 34(11):1332-1336.
[11] Dai X, Fang X, Xia Y, et al. ATP-activated P2X7R promote the attack of acute gouty arthritis in rats through activating NLRP3 inflammasome and inflammatory cytokine production[J]. J Inflamm Res, 2022, 15(1):1237-1248.
[12] Li XH, Xiang N. Effects of Danshensu on myocardial fibrosis in rats with acute myocardial infarction[J]. Journal of Chinese Medicinal Materials, 2020, 43(2):473-477. (in Chinese)
李湘海, 向凝. 丹参素对急性心肌梗死大鼠心肌纤维化的影响[J]. 中药材, 2020, 43(2):473-477.
[13] Han X, Yang Y, Zhang M, et al. Liquiritin protects against cardiac fibrosis after myocardial infarction by inhibiting CCL5 expression and the NF-κB signaling pathway[J]. Drug Des Devel Ther, 2022, 16(1):4111-4125.
[14] Fang R, Ju D, Han M, et al. Progress on the role and mechanism of macrophage phenotypic changes in myocardial fibrosis[J]. Journal of Ningxia Medical University, 2024, 46(2):204-210. (in Chinese)
方容, 鞠迪, 韩曼, 等. 巨噬细胞表型改变在心肌纤维化中的作用和机制研究进展[J]. 宁夏医科大学学报, 2024, 46(2):204-210.
[15] Li J, Wang YQ, Zhan XH, et al. Summary of experience in the diagnosis and treatment of chronic heart failure[J]. Clinic Research of Tradition Chinese Medical, 2023, 15(36):56-60. (in Chinese)
李娟, 王昱琪, 战晓慧, 等. 辨治慢性心力衰竭经验摭拾[J]. 中医临床研究, 2023, 15(36):56-60.
[16] Chen RSh, Xiao HZh, Liu N, et al. Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2, GATA4 signaling Pathways[J] Shanxi Journal of Traditional Chinese Medicine, 2022, 43(1):8-12. (in Chinese)
陈仁山, 肖惠珍, 刘宁, 等. 参芪扶正注射液抑制ERK1/2,GATA4信号通路改善小鼠心力衰竭实验研究[J]. 陕西中医, 2022, 43(1):8-12.
[17] Jiang JG, Du XM, Yao YM, et al. Effects of Huangqishengmaiyin on cardiac function, immune function and expression of plasma miRNA-155 in patients with coronary heart disease and heart failure[J]. Journal of Electrocardiology and Circulation, 2021, 40(3):262-266. (in Chinese)
蒋健刚, 杜晓马, 姚宇玫, 等. 黄芪生脉饮对冠心病心力衰竭患者心功能,免疫功能和外周血miRNA-155表达的影响[J]. 心电与循环, 2021, 40(3):262-266.
[18] Zhang G, Han X, Xu T, et al. Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway[J]. J Ethnopharmacol, 2024, 320(1):117388-117398.
[19] Zhang X, Tian B, Cong X, et al. SLIT3 promotes cardiac fibrosis and differentiation of cardiac fibroblasts by RhoA/ROCK1 signaling pathway[J]. Iran J Basic Med Sci, 2024, 27(7):832-840.
[20] Zhang X, Qu H, Yang T, et al. LuQi formula ameliorates myocardial fibrosis by suppressing TLR4/MyD88/NF-κB pathway and NLRP3 inflammasome activation in mice with myocardial infarction[J]. Evid Based Complement Alternat Med, 2022, 2022(1):5867987-5867996.
[21] Fan J, Ren M, Chen W, et al. Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats[J]. Int Immunopharmacol, 2023, 121(1):110511-110520.
[22] Zhou J, Tian G, Quan Y, et al. Inhibition of P2X7 purinergic receptor ameliorates cardiac fibrosis by suppressing NLRP3/IL-1β pathway[J]. Oxid Med Cell Longev, 2020, 2020(1):7956274-7956282.
[23] Liu N, Gong Z, Li Y, et al. CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats[J]. J Hypertens, 2024, 42(2):315-328.